Bleomycin in germ cell tumor therapy: Not all regimens are created equal

被引：13
作者：
Bajorin, DF
Bosl, GJ
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1997年 / 15卷 / 05期
关键词：
D O I：
10.1200/JCO.1997.15.5.1717
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1717 / 1719
页数：3
相关论文
共 11 条
[1]   COMPARISON OF CRITERIA FOR ASSIGNING GERM-CELL TUMOR PATIENTS TO GOOD RISK AND POOR RISK STUDIES [J].
BAJORIN, D ;
KATZ, A ;
CHAN, E ;
GELLER, N ;
VOGELZANG, N ;
BOSL, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :786-792
[2]   RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY [J].
BAJORIN, DF ;
SAROSDY, MF ;
PFISTER, DG ;
MAZUMDAR, M ;
MOTZER, RJ ;
SCHER, HI ;
GELLER, NL ;
FAIR, WR ;
HERR, H ;
SOGANI, P ;
SHEINFELD, J ;
RUSSO, P ;
VLAMIS, V ;
CAREY, R ;
VOGELZANG, NJ ;
CRAWFORD, ED ;
BOSL, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :598-606
[3]  
Bosl George J., 1997, P1397
[4]   A RANDOMIZED TRIAL OF ETOPOSIDE + CISPLATIN VERSUS VINBLASTINE + BLEOMYCIN + CISPLATIN + CYCLOPHOSPHAMIDE + DACTINOMYCIN IN PATIENTS WITH GOOD-PROGNOSIS GERM-CELL TUMORS [J].
BOSL, GJ ;
GELLER, NL ;
BAJORIN, D ;
LEITNER, SP ;
YAGODA, A ;
GOLBEY, RB ;
SCHER, H ;
VOGELZANG, NJ ;
AUMAN, J ;
CAREY, R ;
FAIR, WR ;
HERR, H ;
MORSE, M ;
SOGANI, P ;
WHITMORE, W .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (08) :1231-1238
[5]   Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: A randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group [J].
deWit, R ;
Stoter, G ;
Kaye, SB ;
Sleijfer, DT ;
Jones, WG ;
Huinink, WWT ;
Rea, LA ;
Collette, L ;
Sylvester, R .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1837-1843
[6]   EVALUATION OF OPTIMAL DURATION OF CHEMOTHERAPY IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - A SOUTHEASTERN-CANCER-STUDY-GROUP PROTOCOL [J].
EINHORN, LH ;
WILLIAMS, SD ;
LOEHRER, PJ ;
BIRCH, R ;
DRASGA, R ;
OMURA, G ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) :387-391
[7]  
HORWICH A, 1984, ETOPOSIDE VP16 CURRE, P233
[8]  
HORWICH A, 1994, P AN M AM SOC CLIN, V13, P230
[9]  
*INT GERM CELL CAN, 1997, J CLIN ONCOL, V15, P594
[10]   IMPORTANCE OF BLEOMYCIN IN FAVORABLE-PROGNOSIS DISSEMINATED GERM-CELL TUMORS - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP TRIAL [J].
LOEHRER, PJ ;
JOHNSON, D ;
ELSON, P ;
EINHORN, LH ;
TRUMP, D .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :470-476
12